The executive vice-chairman of embattled Middle East healthcare operator NMC Health (NMC) sold £55.7m worth of shares, it has been revealed.
Announced last week, the trade settled on Friday and revealed Khaleefa Butti Omair Yousif Al Muhairi, who led NMC Health’s London IPO in 2012, offloaded 4.6m shares at £12 apiece.
Al Muhairi sold the shares along with well-known Abu Dhabi -based investor Saeed Mohamed al-Qebaisi, with the duo parting with a combined 15% stake in the group.
In its statement last week, NMC insisted the duo remain ‘supportive and long-term investors in NMC’.
Al Muhairi is also chairman of virus-hit foreign exchange company Travelex, following the takeover of the business in 2014 by Abu Dhabi-based private equity company Centurion Investments, a big shareholder in NMC Health and of which Al Muhairi is also executive vice-chairman.
BILLIONAIRE UNLOADS SOME SUMMIT
billionaire venture capitalist Robert Duggan sold £7m worth of shares in pharmaceutical company Summit Threapeutics (SUMM:AIM).
Non-executive director Duggan led a fundraising round at the end of December which raised £38m in total, and has now sold a chunk of shares, offloading 33m shares in total at 22.1 apiece for a total of £7.3m.
Despite the sale, the serial entrepreneur still holds 62.85% of the company’s issued share capital.
Summit Therapeutics plans to delist from AIM on 24 February.
Meanwhile, the finance boss of audio and music products company Focusrite (TUNE:AIM) sold a big wad of shares in the business for a cool £1.2m.
Chief financial officer Jeremy Wilson offloaded 171,640 shares at a price of 671.6p each. Following the sale, Wilson holds around 197,000 shares representing 0.3% of the total number of shares in the company.
Every Thursday, Shares will roundup the biggest director deals over the past week.
For a full list of the past week’s most significant director trades, click here.
